跳至主要内容
临床试验/NCT07114653
NCT07114653招募中不适用

The Role of POLE Mutation in High Risk Endometrial Cancer.

Far Eastern Memorial Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2025年9月1日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
1
主要终点
Prevalence of POLE mutation in high risk endometrial cancer

研究概览

简要总结

The actual role of POLE mutations in high-risk endometrial cancer is undetermined. The main question it aims to answer is:

What is the prevalence of POLE mutations in high-risk endometrial cancer case? What is the impact of POLE mutations in real world high-risk endometrial cancer case?

详细描述

All high-risk recurrent endometrial cancer cases who were treated in a tertiary referral center will be analyzed and subjected to POLE mutation analysis. In addition, survival analysis will be used to analyze the role of POLE mutations in women with high-risk endometrial cancer. We can answers the following.

  1. What is the prevalence of POLE mutations in women with high-risk endometrial cancer?
  2. What is the role of POLE mutations in real world high-risk endometrial cancer?

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • women with high-risk for recurrent endometrial cancer

排除标准

  • 未提供

结局指标

主要结局

Prevalence of POLE mutation in high risk endometrial cancer

时间窗: 2 years

The prevalence of POLE mutations in women with high-risk for recurrent endometrial cancer

次要结局

  • The impact of POLE on overall survival(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sheng-Mou Hsiao

Chief, Department of Obstetrics & Gynecology

Far Eastern Memorial Hospital

研究点 (1)

Loading locations...

相似试验